SYNKRINO BIOTHERAPEUTICS
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric rheumatologists for life-threatening conditions. It is currently building a rapid, portable field test for the RNA virus 2019-nCoV/COVID-19, adapting its existing analytic protocols for community public health screening. Synkrino Biotherapeutics' therapeutics use AI + Immunology Discovery Engine (AIDE Engine) which applies neural networks and machine learning to measure the immune tissue from patients to repeatably discover novel and biologically-valid drug targets, enabling healthcare providers to cure their patients and improve their lives.
SYNKRINO BIOTHERAPEUTICS
Industry:
Artificial Intelligence (AI) Biotechnology Health Care Therapeutics
Founded:
2018-01-01
Address:
Berkeley, California, United States
Country:
United States
Website Url:
http://www.synkrino.bio
Total Employee:
1+
Status:
Active
Technology used in webpage:
Amazon Google Apps For Business Cloudflare DNS AWS Global Accelerator Webflow
Similar Organizations
ActiveO
ActiveO, a spine technology company, develops and delivers image-guided therapies to treat back pain.
IBIS Therapeutics
IBIS Therapeutics is accelerating drug discovery through Molecular Fingerprintâ„¢ Platform
N.A. Genomics
N.A. Genomics is a Personal Health AI Platform that helps to optimize health based on DNA information and other characteristics.
Nivalis Therapeutics
Nivalis Therapeutics is a clinical-stage pharmaceutical company developing a novel class of disease modifying therapies.
TransAxon
Reality-level Brain Computer Interfaces
Current Employees Featured
Founder
Investors List
Endpoint Ventures
Endpoint Ventures investment in Seed Round - Synkrino Biotherapeutics
Y Combinator
Y Combinator investment in Seed Round - Synkrino Biotherapeutics
Official Site Inspections
http://www.synkrino.bio
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Synkrino Biotherapeutics"
Synkrino Biotherapeutics - PitchBook
Www.synkrino.bio. Ownership Status. Out of Business. Financing Status. Formerly VC-backed. Corporate Office. 1111 Broadway; Oakland, CA 94607; United States; Primary Industry. ... Synkrino Biotherapeutics’s primary industry …See details»
Synkrino Biotherapeutics - Y Combinator
Synkrino's AI, SATIS is a powerful, unbiased discovery system for…. Founded in by Jason Barbour and David Ott, Synkrino Biotherapeutics has 2 employees based in Oakland, CA, USA.See details»
Synkrino development company
Synkrino Development Company Synkrino Development Company Synkrino Development Company. A New Approach to Drug Development. Thousands of medical breakthroughs never make it past a lab bench. Development failures …See details»
Synkrino Biotherapeutics - VentureRadar
Synkrino Bio's AIDE Engine discovers and develops novel drug targets directly from the immune system of patients. The AI + Immunology Discovery Engine has identified two novel drug …See details»
Synkrino Biotherapeutics, Inc. - Drug pipelines, Patents, Clinical ...
Last update 07 Mar 2025. Synkrino Biotherapeutics, Inc. Startups |See details»
Synkrino Biotherapeutics - Golden
Synkrino Biotherapeutics is a Berkeley, California-based biotechnology platform working on discovering and developing novel drug targets from the immune system of patients. ...See details»
Synkrino Biotherapeutics - Berkeley Emeryville BIO
Synkrino Biotherapeutics. C/O Citris Foun, UC Berkeley 450 Sutardja Dai Hall. Berkeley. Website. Developer of novel therapeutics designed to treat patients with diseases driven by the immune …See details»
Synkrino Biotherapeutics Company Profile - Office Locations ...
Synkrino Biotherapeutics has 5 employees at their 1 location. See insights on Synkrino Biotherapeutics including office locations, competitors, revenue, financials, executives, …See details»
Synkrino Biotherapeutics, Inc. - Company Profile - Corporation Wiki
Jun 14, 2018 Synkrino Biotherapeutics, Inc. Overview. Synkrino Biotherapeutics, Inc. filed as a Statement & Designation By Foreign Corporation in the State of California on Thursday, June …See details»
SDC | Leadership Team - synkrino.dev
Profile: PhD, life science, med. chem, drug discovery and drug development. Professional background: GSK, LEO PharmaSee details»
Synkrino Biotherapeutics - Funding, Financials, Valuation & Investors
Aug 23, 2018 How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Aug 23, …See details»
Home - Synklino
Live life again We develop transformative therapies for the elimination of the risk for chronic viral diseases We strive to improve the quality of life of transplant recipients Transplantation is …See details»
SYNKRINO BIOTHERAPEUTICS INC Oakland CA, 94607 - Company …
Free Business profile for SYNKRINO BIOTHERAPEUTICS INC at 1111 Broadway, Oakland, CA, 94607-4139, US.See details»
Synkrino Biotherapeutics - Company Information | YCDB - The Y ...
Synkrino Biotherapeutics. Synkrino Bio's AIDE Engine discovers and develops novel drug targets directly from the immune system... Live. Statistics. Compare to all YC; Compare to S18; …See details»
David Ott - Synkrino Biotherapeutics - LinkedIn
David and I developed Synkrino Bio in early 2018, working from offices in the Berkeley School of Engineering, before joining Y Combinator that summer.See details»
Synkrino Biotherapeutics - CoBee Company Profile & Funding …
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. The platform is providing monitoring for pediatric …See details»
Value Proposition - SDC
Synkrino Development Company partners with biotech to finance and develop innovative high impact therapeutics programs. We serve the entire pharma ecosystem of patients, prescribers, …See details»
Synkrino Biotherapeutics - Updates, News, Events, Signals & Triggers
Oct 24, 2022 Organization. Synkrino Biotherapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Research and …See details»
Synkrino Biotherapeutics - Contacts, Employees, Board Members, …
Synkrino Biotherapeutics is a biotech platform that discovers and develops novel drug targets directly from the immune system of patients. ... Experience the new Crunchbase, powered by …See details»
Welcome to BIO 2025: Collaboration can't wait. | BIO
2 days ago As we kick off BIO 2025, the world’s largest biotech gathering, BIO emphasizes that collaboration can’t wait. Today’s theme: Collaboration—between government and industry, …See details»